Wild Bird Therapeutics Hong Kong Limited participated in a strategic discussion session with Shenzhen Bay Laboratory during its visit to Guangming Science City, one of Shenzhen’s key hubs for biomedical research and life sciences innovation.
The program also included visits and exchanges with other scientific and life sciences sites included in the itinerary, such as Guangming Urban Planning Exhibition Hall / Guangming Science City Exhibition Center, CellBri, and “Bay Power” Weiguang Life Science Park.
These meetings provided an opportunity to better understand Shenzhen’s growing biomedical ecosystem, including research infrastructure, advanced therapies, biomanufacturing, life sciences parks and translational innovation.
During the sessions, Wild Bird Therapeutics shared its vision for advancing next-generation oncology therapeutics by integrating artificial intelligence, molecular dynamics, biophysics and translational science.
The discussions opened the door to potential future collaborations with research institutions, life sciences companies and innovation platforms across the Greater Bay Area.